דטסקאן

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

IOFLUPANE

Verfügbar ab:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATC-Code:

V09AB03

Darreichungsform:

תמיסה להזרקה

Zusammensetzung:

IOFLUPANE 74 MBQ/ML

Verabreichungsweg:

תוך-ורידי

Verschreibungstyp:

מרשם נדרש

Hergestellt von:

GE HEALTHCARE B.V., THE NETHERLAND

Therapiegruppe:

OTHER DOPAMINERGIC AGENTS

Therapiebereich:

IODINE IOFLUPANE (123I)

Anwendungsgebiete:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Berechtigungsdatum:

2014-11-30